• UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome)
  • CD4 T-Cell Recent Thymic Emigrants (RTE)
  • Strata Select™, EpiSwitch® CiRT for Immunotherapy Management
  • IriSight™ Prenatal Analysis
  • FoundationFocus CDxBRCA
  • Tissue Transglutaminase (tTG) Antibody, IgG
  • Epidermal Growth Factor Receptor (EGFR), IHC
  • Apolipoprotein B, Serum
  • Prostatic Acid Phosphatase (PAP)
  • Protean BioDiagnostics Lung HDPCR™ for Non-Small Cell Lung Cancer (NSCLC)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CBFB-MYH11 inv(16) Gene Fusion, Quantitative
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CBFB-MYH11 inv(16) Gene Fusion, Quantitative
Medical Test

Interpretation
Access to CBFB-MYH11 inv(16) Gene Fusion, Quantitative is restricted.
Loading...